Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2010, Article ID 285974, 5 pages
http://dx.doi.org/10.4061/2010/285974
Research Article

Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G Allele

Department of Medical Genetics and Child Development, University of Pecs, Pecs 7624, Hungary

Received 4 June 2009; Accepted 2 August 2009

Academic Editor: Rizgar Mageed

Copyright © 2010 Bernadett Farago et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Magistrelli, P. Jeannin, G. Elson et al., “Identification of three alternatively spliced variants of human CD28 mRNA,” Biochemical and Biophysical Research Communications, vol. 259, no. 1, pp. 34–37, 1999. View at Publisher · View at Google Scholar
  2. L. Nistico, R. Buzzetti, L. E. Pritchard et al., “The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian diabetes registry,” Human Molecular Genetics, vol. 5, no. 7, pp. 1075–1080, 1996. View at Google Scholar
  3. P. A. Zalloua, A. Abchee, H. Shbaklo et al., “Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene,” Human Immunology, vol. 65, no. 7, pp. 719–724, 2004. View at Google Scholar
  4. H. Donner, J. Braun, C. Seidl et al., “Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in hashimoto's thyroiditis and addison's disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 12, pp. 4130–4132, 1997. View at Google Scholar
  5. A. Blomhoff, B. A. Lie, and A. G. Myhre, “Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to addison's disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 7, pp. 3474–3476, 2004. View at Google Scholar
  6. J. M. Heward, A. Allahabadia, M . Armitage et al., “The development of Graves' disease and the CTLA-4 gene on chromosome 2q33,” The Journal of Clinical Endocrinology & Metabolism, vol. 84, no. 7, pp. 2398–2401, 1994. View at Google Scholar
  7. Y. Ban, E. S. Concepcion, R. Villanueva et al., “Analysis of immune regulatory genes in familial and sporadic graves' disease,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4562–4568, 2004. View at Publisher · View at Google Scholar
  8. K. Furugaki, S. Shirasawa, N. Ishikawa et al., “Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the japanese,” Journal of Human Genetics, vol. 49, no. 3, pp. 166–168, 2004. View at Publisher · View at Google Scholar
  9. V. Suppiah, I. Alloza, S. Heggrty et al., “The CTLA4 +49 A/G* G-CT60* G haplotype is associated with susceptibility to multiple sclerosis in flanders,” Journal of Neuroimmunology, vol. 164, no. 1-2, pp. 148–153, 2005. View at Publisher · View at Google Scholar
  10. G. Malferrari, A. Stella, E. Monferini et al., “Ctla4 and multiple sclerosis in the italian population,” Experimental and Molecular Pathology, vol. 78, no. 1, pp. 55–57, 2005. View at Publisher · View at Google Scholar
  11. A. Ligers, N. Teleshova, T. Masterman et al., “CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms,” Genes and Immunity, vol. 2, no. 3, pp. 145–152, 2001. View at Publisher · View at Google Scholar
  12. A. L. King, S. J. Moodie, J. S. Fraser et al., “Coeliac disease: investigation of proposed causal variants in the CTLA4 gene region,” European Journal of Immunogenetics, vol. 30, no. 6, pp. 427–432, 2003. View at Publisher · View at Google Scholar
  13. M. J. van Belzen, C. J. Mulder, A. Zhernakova et al., “CTLA4 + 49 A/G and CT60 polymorphisms in Dutch coeliac disease patients,” European Journal of Human Genetics, vol. 12, no. 9, pp. 782–785, 2004. View at Publisher · View at Google Scholar
  14. V. Suppiah, C. O'Doherty, S. Heggarty et al., “The CTLA4 + 49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland,” Experimental and Molecular Pathology, vol. 80, no. 2, pp. 141–146, 2006. View at Publisher · View at Google Scholar
  15. B. Vaidya, S. H. Pearce, S. Charlton et al., “An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies,” Rheumatology, vol. 41, no. 2, pp. 180–183, 2002. View at Google Scholar
  16. A. Barton, A. Myerscough, S. John et al., “A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis,” Rheumatology, vol. 39, no. 1, pp. 63–66, 2000. View at Google Scholar
  17. C. Seidl, H. Donner, B. Fischer et al., “CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis,” Tissue Antigens, vol. 51, no. 1, pp. 62–66, 1998. View at Google Scholar
  18. A. Zhernakova, P. Eerligh, P. Barrera et al., “CTLA4 is differentially associated with autoimmune diseases in the Dutch population,” Human genetics, vol. 118, no. 1, pp. 58–66, 2005. View at Google Scholar
  19. R. M. Plenge, L. Padyukov, E. F. Remmers et al., “Replication of putative candidate-gene associations with rheumatoid arthritis in > 4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4,” American Journal of Human Genetics, vol. 77, no. 6, pp. 1044–1060, 2005. View at Publisher · View at Google Scholar
  20. H. Ueda, J. M. Howson, L. Esposito et al., “Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease,” Nature, vol. 423, no. 6939, pp. 506–511, 2003. View at Publisher · View at Google Scholar
  21. C.-S. Lee, Y.-J. Lee, H.-F. Liu et al., “Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese,” Clinical Rheumatology, vol. 22, no. 3, pp. 221–224, 2003. View at Publisher · View at Google Scholar
  22. G. Orozco, B. Torres, A. Nunez-Roldan et al., “Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis,” Tissue Antigens, vol. 64, no. 6, pp. 667–670, 2004. View at Publisher · View at Google Scholar
  23. S. M. Anjos, W. Shao, L. Marchand et al., “Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' + 6230G > A polymorphism,” Genes and Immunity, vol. 6, no. 4, pp. 305–311, 2005. View at Publisher · View at Google Scholar
  24. M. Maurer, S. Loserth, A. Kolb-Maurer et al., “A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation,” Immunogenetics, vol. 54, no. 1, pp. 1–8, 2002. View at Publisher · View at Google Scholar
  25. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar
  26. B. Farago, G. C. Talian, A. Maasz et al., “Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies,” Clinical and Experimental Rheumatology, vol. 25, no. 4, pp. 523–528, 2007. View at Google Scholar
  27. B. Farago, L. Magyari, E. Safrany et al., “Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 67, no. 2, pp. 248–250, 2008. View at Publisher · View at Google Scholar
  28. K. Komlosi, G. C. Talian, B. Farago et al., “No infiuence of SLC22A4 C6607T and RUNX1 G24658C genotypic variants on the circulating carnitine ester profile in patients with rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 26, no. 1, pp. 61–66, 2008. View at Google Scholar
  29. C. Lei, Z. Dongqing, S. Yeqing et al., “Association of the CTLA-4 gene with rheumatoid arthritis in chinese han population,” European Journal of Human Genetics, vol. 13, no. 7, pp. 823–828, 2005. View at Publisher · View at Google Scholar
  30. M. Matsushita, N. Tsuchiya, M. Shiota et al., “Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in japanese: an association study using a novel variation screening method,” Tissue Antigens, vol. 54, no. 6, pp. 578–584, 1999. View at Publisher · View at Google Scholar
  31. T. Yanagawa, K. Gomi, E. I. Nakao et al., “CTLA-4 gene polymorphism in japanese patients with rheumatoid arthritis,” Journal of Rheumatology, vol. 27, no. 12, pp. 2740–2742, 2000. View at Google Scholar
  32. S. Purohit, R. Podolsky, C. Collins et al., “Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes,” Journal of Autoimmune Diseases, vol. 2, no. 8, 2005. View at Google Scholar